[Form 4] Catheter Precision, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Catheter Precision, Inc. Chairman and CEO David A. Jenkins reported derivative holdings in Series M Common Stock Purchase Warrants. On December 31, 2025, he reported 170,000 Series M warrants at an exercise price of $1.56 per underlying common share held directly, and another 170,000 Series M warrants at the same exercise price held indirectly.

The warrants are initially exercisable any time on or after the stockholder approval date, and each warrant terminates on the five and one half year anniversary of its initial exercise date. The indirect position is associated with FatBoy Capital LP, whose general partner is SeaCap Management LLC, where Mr. Jenkins serves as managing member.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider JENKINS DAVID A

Role Chairman of the Board and CEO

Type	Security	Shares	Price	Value
Other	Series M Common Stock Purchase Warrant	170,000	$1.56	$265K
Other	Series M Common Stock Purchase Warrant	170,000	$1.56	$265K

Holdings After Transaction: Series M Common Stock Purchase Warrant — 170,000 shares (Direct); Series M Common Stock Purchase Warrant — 170,000 shares (Indirect, See Footnote 3)

Footnotes (1)

1. Initial Exercise Date is any time on or after the Stockholder Approval Date. Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JENKINS DAVID A

(Last) (First) (Middle)

1670 HIGHWAY 160 WEST

SUITE 205

(Street)

FORT MILL SC 29708

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Catheter Precision, Inc. [ VTAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman of the Board and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series M Common Stock Purchase Warrant	$1.56	12/31/2025		J		170,000		(1)	(2)	Common Stock	170,000	$1.56	170,000	D
Series M Common Stock Purchase Warrant	$1.56	12/31/2025		J		170,000		(1)	(2)	Common Stock	170,000	$1.56	170,000	I	See Footnote 3(3)

Explanation of Responses:

1. Initial Exercise Date is any time on or after the Stockholder Approval Date.

2. Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date

3. Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP

	/s/ David A Jenkins	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.